ITGB2-AS1

gene
On this page

Summary

ITGB2-AS1 (ITGB2 antisense RNA 1, HGNC:44304) is a long non-coding RNA gene on chromosome 21q22.3.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:44304
Approved symbolITGB2-AS1
NameITGB2 antisense RNA 1
Location21q22.3
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000227039
Ensembl biotypelncRNA
Entrez100505746
RNAcentralURS000075A18C — lncRNA, 2425 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 11 lncRNA

ENST00000429132, ENST00000441379, ENST00000608043, ENST00000609592, ENST00000609694, ENST00000610063, ENST00000688945, ENST00000692198, ENST00000798960, ENST00000798961, ENST00000832784

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000429132 — 3 exons

ExonStartEnd
ENSE000015989014492785444928028
ENSE000016174424492686844927004
ENSE000016403764492132644921351

Expression profiles

Bgee: expression breadth ubiquitous, 206 present calls, max score 98.07.

FANTOM5 (CAGE): breadth broad, TPM avg 5.2287 / max 193.3725, expressed in 618 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
1895091.6670405
1895061.1053224
1895110.9820168
1895120.9373227
1895100.3976198
1895080.080223
1895070.059228

Top tissues by expression

233 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
granulocyteCL:000009498.07gold quality
bloodUBERON:000017895.15gold quality
thymusUBERON:000237094.65gold quality
monocyteCL:000057692.94gold quality
leukocyteCL:000073892.47gold quality
spleenUBERON:000210692.29gold quality
lymph nodeUBERON:000002992.04gold quality
trabecular bone tissueUBERON:000248390.07gold quality
bone marrowUBERON:000237189.12gold quality
epithelium of nasopharynxUBERON:000195189.02gold quality
vermiform appendixUBERON:000115488.56gold quality
pancreatic ductal cellCL:000207987.35silver quality
ileal mucosaUBERON:000033186.41gold quality
epithelial cell of pancreasCL:000008385.83silver quality
tonsilUBERON:000237284.59gold quality
caecumUBERON:000115384.45gold quality
bone marrow cellCL:000209283.41gold quality
superficial temporal arteryUBERON:000161483.31gold quality
nasal cavity epitheliumUBERON:000538481.52silver quality
palpebral conjunctivaUBERON:000181279.73gold quality
tibiaUBERON:000097979.33gold quality
buccal mucosa cellCL:000233677.61gold quality
mucosa of transverse colonUBERON:000499177.20gold quality
upper arm skinUBERON:000426377.09gold quality
kidney epitheliumUBERON:000481976.58gold quality
gall bladderUBERON:000211076.27gold quality
parietal pleuraUBERON:000240075.56gold quality
upper lobe of left lungUBERON:000895275.30gold quality
upper lobe of lungUBERON:000894874.52gold quality
superior surface of tongueUBERON:000737174.00gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.14

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 7)

  • LncRNA ITGB2-AS1 could promote the migration and invasion of breast cancer cells by up-regulating ITGB2. (PMID:29941860)
  • study suggested that ITGB2-AS1 played critical roles in the development and progression of osteosarcoma via Wnt/beta-catenin signalling, indicating that ITGB2-AS1 might be a valuable diagnostic biomarker and potential anticancer therapeutic target for osteosarcoma. (PMID:30260245)
  • Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. (PMID:32165090)
  • LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis. (PMID:34170494)
  • [Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia]. (PMID:34627422)
  • The expression and significance of long non-coding RNA ITGB2-AS1 in renal clear cell carcinoma. (PMID:36634939)
  • LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis. (PMID:37370246)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.